This study will compare the safety and gastrointestinal tolerability of Ferric Maltol oral suspension and Ferrous Sulfate oral liquid in children and adolescents in ages 2-17 years, diagnosed with anemia. The study will be for a total of 12 weeks, and up to 5 visits. There will be blood work in study, and possible urine test.
Criteria:Subjects aged 2 to 17 years
Parent or Gardian must sign Consent form
Subjects 14-17 years of age must sign Consent form
Subjects diagnosed with Iron Deficiency Anemia, can be determine with blood work
Subjects of childbearing potential must agree to use a highly effective method of contraception (complete abstinence is included)
Subjects will not be able to get into the study if they have anemia due to any cause other than iron deficiency, including, but not limited to due to untreated or untreatable severe malabsorption syndrome
Subjects will not be able to join the study if they have12 weeks of blood transfusion or is scheduled to have blood transfusion or donation, can join the study after under the discretion of the Principal Investigator.
Subjects will be required to have blood work, and potential urine screen.
Subjects will not be able to be part of the study if there is history of active peptic ulcer
Subject will not be able to be part of the Study if they are Diagnosed to be COVID-19 positive by (SARS-CoV-2-RT-PCR positive) within 28 days prior to screening